NO20000301L - Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasøytiske blandinger som inneholder den - Google Patents

Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasøytiske blandinger som inneholder den

Info

Publication number
NO20000301L
NO20000301L NO20000301A NO20000301A NO20000301L NO 20000301 L NO20000301 L NO 20000301L NO 20000301 A NO20000301 A NO 20000301A NO 20000301 A NO20000301 A NO 20000301A NO 20000301 L NO20000301 L NO 20000301L
Authority
NO
Norway
Prior art keywords
carbazolyloxy
methoxyphenoxy
ethylamino
propanol
preparation
Prior art date
Application number
NO20000301A
Other languages
English (en)
Other versions
NO313588B1 (no
NO20000301D0 (no
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO20000301L publication Critical patent/NO20000301L/no
Publication of NO20000301D0 publication Critical patent/NO20000301D0/no
Publication of NO313588B1 publication Critical patent/NO313588B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20000301A 1997-07-22 2000-01-21 Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte forfremstilling derav og farmasöytiske blandinger som inneholder den NO313588B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
PCT/EP1998/004475 WO1999005105A1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (3)

Publication Number Publication Date
NO20000301L true NO20000301L (no) 2000-01-21
NO20000301D0 NO20000301D0 (no) 2000-01-21
NO313588B1 NO313588B1 (no) 2002-10-28

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000301A NO313588B1 (no) 1997-07-22 2000-01-21 Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte forfremstilling derav og farmasöytiske blandinger som inneholder den

Country Status (31)

Country Link
EP (2) EP0893440A1 (no)
JP (1) JP2001510824A (no)
KR (1) KR100336229B1 (no)
CN (1) CN1125047C (no)
AR (1) AR015133A1 (no)
AT (1) ATE236123T1 (no)
AU (1) AU740453B2 (no)
BR (1) BR9810776A (no)
CA (1) CA2296637C (no)
CZ (1) CZ296947B6 (no)
DE (1) DE69812964T2 (no)
DK (1) DK1000027T3 (no)
ES (1) ES2195366T3 (no)
HR (1) HRP980406A2 (no)
HU (1) HUP0003198A3 (no)
IL (1) IL133677A (no)
MA (1) MA26523A1 (no)
MY (1) MY117734A (no)
NO (1) NO313588B1 (no)
NZ (1) NZ502136A (no)
PE (1) PE96999A1 (no)
PL (1) PL191602B1 (no)
PT (1) PT1000027E (no)
RU (1) RU2202542C2 (no)
SI (1) SI1000027T1 (no)
TR (1) TR200000148T2 (no)
TW (1) TW505631B (no)
UY (1) UY25108A1 (no)
WO (1) WO1999005105A1 (no)
YU (1) YU2200A (no)
ZA (1) ZA986475B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074356A1 (en) * 2000-04-03 2001-10-11 F. Hoffmann-La Roche Ag Concentrated solutions of carvedilol
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
IL153688A0 (en) 2000-06-28 2003-07-06 Teva Pharma Carvedilol
JP2004534840A (ja) * 2001-07-13 2004-11-18 スミスクライン・ビーチャム・コーポレイション カルベジロール多型体
EP1929998A3 (en) 2001-09-21 2008-11-26 Egalet A/S Controlled release solid dispersions of carvedilol
WO2003029214A1 (en) * 2001-09-28 2003-04-10 F. Hoffmann-La Roche Ag Pseudopolymorphic forms of carvedilol
PL371409A1 (en) 2002-01-15 2005-06-13 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
JP2006500320A (ja) * 2002-04-30 2006-01-05 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール一クエン酸塩一水和物
AU2003251627A1 (en) 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
MXPA04012923A (es) * 2002-06-27 2005-03-31 Sb Pharmco Inc Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
WO2004094378A1 (en) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
JP2007512372A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
CA2589699A1 (en) * 2004-12-09 2006-06-15 Zach System S.P.A. Process for the preparation of carvedilol and its enantiomers
EP1781611A1 (en) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Crystalline forms of carvedilol and processes for their preparation
WO2008002683A2 (en) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
DE69812964D1 (de) 2003-05-08
YU2200A (sh) 2002-03-18
UY25108A1 (es) 2000-12-29
AU8631998A (en) 1999-02-16
IL133677A (en) 2004-06-01
EP1000027B1 (en) 2003-04-02
RU2202542C2 (ru) 2003-04-20
PT1000027E (pt) 2003-07-31
TR200000148T2 (tr) 2000-07-21
TW505631B (en) 2002-10-11
DE69812964T2 (de) 2004-03-04
ES2195366T3 (es) 2003-12-01
NO313588B1 (no) 2002-10-28
BR9810776A (pt) 2000-09-19
HUP0003198A2 (en) 2001-03-28
HUP0003198A3 (en) 2002-10-28
WO1999005105A1 (en) 1999-02-04
HRP980406A2 (en) 1999-04-30
MA26523A1 (fr) 2004-12-20
JP2001510824A (ja) 2001-08-07
HK1029339A1 (en) 2001-03-30
KR20010022097A (ko) 2001-03-15
CA2296637A1 (en) 1999-02-04
EP0893440A1 (en) 1999-01-27
DK1000027T3 (da) 2003-07-21
ZA986475B (en) 2000-01-21
AR015133A1 (es) 2001-04-18
PE96999A1 (es) 1999-10-12
KR100336229B1 (ko) 2002-05-09
CN1125047C (zh) 2003-10-22
NZ502136A (en) 2002-05-31
CN1264366A (zh) 2000-08-23
AU740453B2 (en) 2001-11-01
CA2296637C (en) 2005-11-15
NO20000301D0 (no) 2000-01-21
CZ296947B6 (cs) 2006-08-16
PL338432A1 (en) 2000-11-06
SI1000027T1 (en) 2003-10-31
IL133677A0 (en) 2001-04-30
CZ2000221A3 (cs) 2000-05-17
ATE236123T1 (de) 2003-04-15
EP1000027A1 (en) 2000-05-17
MY117734A (en) 2004-07-31
PL191602B1 (pl) 2006-06-30

Similar Documents

Publication Publication Date Title
NO20000301D0 (no) Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasoeytiske blandinger som inneholder den
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
NO942834D0 (no) 1-benzensulfonyl-1,3-dihydro-indol-2-on-derivater, fremstilling derav, og farmasöytiske blandinger som inneholder dem
EE200000707A (et) Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200200409A (et) 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO20005430L (no) 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser
HUP0101434A3 (en) Sulfonamide-containing indole compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing the same
NO20031619D0 (no) Substituerte indoler, farmasöytiske blandinger inneholdende slike indoler og deres anvendelse som PPAR-gamma-bindende midler
NO20024891L (no) Farmasöytiske sammensetninger
DK1001813T3 (da) Farmaceutiske formuleringer indeholdende voriconazol
DK1024794T3 (da) Fremgangsmåde til behandling af kapsler og törre, pulveriserede farmaceutiske formuleringer
HUP0203873A3 (en) Substituted indole mannich bases, process for their preparation and pharmaceutical compositions containing them
NO984290L (no) Farmas°ytisk nyttige forbindelser
HUP0401499A3 (en) Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them
AU9416201A (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
HUP0004345A3 (en) Novel oral pharmaceutical compositions containing from carvedilol
PL370412A1 (en) Pseudopolymorphic forms of carvedilol
HUP0201338A2 (en) Novel indole derivatives, pharmaceutical compositions containing them and their use
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
AU2002346457A8 (en) Pharmaceutical formulations comprising indolinone derivatives
EE04437B1 (et) (1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200100499A (et) Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO20005158D0 (no) FremgangsmÕte for fremstilling av R-(+)-6-karboksamido-3-N- metylamino-1,2,3,4-tetrahydrokarbazol
DK1105388T3 (da) N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf